文献速递耳科与耳神经小儿耳鼻咽喉

LittlEARs听觉问卷能否区分早期听觉发育差异?

Can Differences in Early Hearing Development Be Distinguished by the LittlEARs Auditory Questionnaire?
PubMed 文献 · Ear Hear · 2020-01-01

本研究回顾性分析43例助听器儿童、43例人工耳蜗儿童和18例听神经病谱系障碍儿童,使用LittlEARs听觉问卷评估早期听觉发育。线性混合效应模型显示人工耳蜗组问卷得分进展快于助听器组和听神经病组,但控制设备使用一致性和可听度后组间差异不显著;发育迟缓儿童在各组的问卷得分改善均更慢。

要点

  • LittlEARs问卷可用于监测幼儿初始听觉发育并辅助早期治疗决策。
  • 人工耳蜗儿童问卷得分进展总体快于助听器和听神经病儿童。
  • 发育迟缓儿童在各组的问卷得分改善均显著更慢。

核心结论

  • LittlEARs听觉问卷是监测幼儿初始听觉发育的有用工具,可辅助早期治疗决策。

研究设计与样本

  • 回顾性纵向研究,纳入43例双侧助听器儿童、43例双侧人工耳蜗儿童和18例佩戴助听设备的听神经病谱系障碍儿童。
  • 听神经病组年龄与无听神经病儿童相似(23个月;SD=15),人工耳蜗组(14个月;SD=8)小于助听器组(24个月;SD=18)[F(2,98.48)=3.4;p=0.04]。
  • 每例完成1至7次LittlEARs问卷,得分范围0至35(均值18.36),采用线性混合效应分析。

主要发现

  • 人工耳蜗儿童问卷得分进展快于助听器或听神经病儿童[χ2(8)=24.51;p=0.002]。
  • 在包含设备使用一致性和可听度(言语可懂度指数或清晰度指数)的子样本中,研究组对问卷改善速率无显著影响(β7=-0.20±0.38,t=-0.52;β8=0.93±0.82,t=1.13;β6=-0.70±1.45,t=-1.87;β7=0.87±0.89,t=0.98)。
  • 所有三组中发育迟缓儿童问卷得分改善显著更慢[χ2(6)=23.60;p<0.001],设备使用一致性有下降趋势[F(1)=3.31;p=0.07]。
  • 人工耳蜗和助听器组更可能达到问卷早期而非后期题目所指示的听觉技能;听神经病组反应变异性较小(人工耳蜗:IQR=9;助听器:IQR=8;听神经病:IQR=1)。
  • 子样本中问卷增长与言语感知结果无关联[r(6)=0.42;p=0.30]。

临床怎么用

  • 可将LittlEARs问卷用于极幼儿的初始听觉发育监测,并作为早期治疗决策的参考。
  • 解读问卷进展时需考虑设备使用一致性和可听度,以及是否合并发育迟缓。

局限性

  • 回顾性研究设计,样本量有限。
  • 组间年龄存在差异,人工耳蜗组常在设备植入前首次完成问卷。
  • 控制设备使用一致性和可听度后组间差异不显著,提示结果受这些因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study asks whether the LittlEARs Auditory Questionnaire (LEAQ), a caregiver measure, can differentiate between the early auditory development of children with bilateral cochlear implants (CIs), bilateral hearing aids (HAs), and children with Auditory Neuropathy Spectrum Disorder (ANSD) who wear CIs or HAs. The LEAQ is sensitive to impaired auditory development but has not previously been used to distinguish developmental changes between groups of children using different hearing technologies or with different types of hearing loss. DESIGN: We collected retrospective longitudinal LEAQ results from 43 children with HAs, 43 with CIs, and 18 with ANSD. The children with ANSD wore hearing technology. They were a similar age to the children without ANSD (23 months; SD = 15), while the CI group (14 months; SD = 8) was younger than the HA group (24 months; SD = 18) [F(2,98.48) = 3.4; p = 0.04]. The CI group often participated in their first LEAQ pretreatment. Participants completed between one and seven LEAQs. Scores ranged between zero and 35 (mean = 18.36). We conducted a linear mixed-effects analysis, which included age or time since device fitting, hearing type (HA, CI, or ANSD), and presence of a comorbidity as fixed effects. A secondary analysis assessed effects of device audibility, measured by the Speech Intelligibility Index or Articulation Index, and consistency of device use obtained from device datalogs. RESULTS: Children with CIs progressed faster than their peers with HAs or ANSD [χ2(8) = 24.51; p = 0.002]. However, within a subsample that included consistency of device use (β7 = -0.20 ± 0.38, t = -0.52; β8 = 0.93 ± 0.82, t = 1.13) and audibility (β6 = -0.70 ± 1.45, t = -1.87; β7 = 0.87 ± 0.89, t = 0.98), study group did not significantly influence rate of improvement on the LEAQ. In addition, children with developmental delays in all three study groups demonstrated significantly slower LEAQ score improvement [χ2(6) = 23.60; p < 0.001] and a trend toward decreased consistency of device use [F(1) = 3.31; p = 0.07]. As we expected, children in the CI and HA groups were more likely to achieve auditory skills indicated in early rather than later LEAQ questions. There was less variability in the responses of the ANSD group [CI: interquartile range (IQR) = 9; HA: IQR = 8; ANSD: IQR = 1]. There was no connection between LEAQ growth and speech perception outcomes in a subsample [r(6) = 0.42; p = 0.30]. CONCLUSIONS: The LEAQ is a useful tool for monitoring initial auditory development in very young children and can inform early treatment decisions.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Ganek H, James A, Papaioannou V, et al. Can Differences in Early Hearing Development Be Distinguished by the LittlEARs Auditory Questionnaire? Ear Hear. 2020. PMID: 31923042. doi:10.1097/AUD.0000000000000821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。